TikTok's Parent Company Acquires Luxury Private Hospital Chain For $1.5B – This And More News In Digital Health This Week
Bertalan Meskó, MD, PhD
Director of The Medical Futurist Institute (Keynote Speaker, Researcher, Author & Futurist)
The most surprising development of last week was undoubtedly ByteDance, TikTok's parent company acquiring one of China's largest private hospital chains, Amcare Healthcare for $1.5B.
ByteDance is the world's largest unicorn, arriving in healthcare relatively late, accelerating its efforts only in 2021. This announcement is by far the most significant step of this journey.
?Everyone wants a piece of the healthcare pie. And as healthcare becomes more expensive, and at the same time, more technology-dependent, don't get surprised if you have to go to a hospital that is owned by a tech company.
"With the acquisition of Amcare, it seems that ByteDance is trying to disrupt the traditional healthcare industry in order to compete with other large tech giants."
Engineers at MIT have created an ultrasound patch that can provide long-term ultrasound imaging of internal organs and structures. This is how they see the future of ultrasound imaging:
“We envision a few patches adhered to different locations on the body, and the patches would communicate with your cellphone, where AI algorithms would analyze the images on demand,”
The ByteDance acquisition highlights how rapidly the healthcare landscape is changing with ever more tech companies entering.
Exactly the reason why we regularly cover all these ventures and help you analyse their significance. This ebook by The Medical Futurist couldn't be more timely.
The Mayo Clinic selected 7 A.I. startups for its accelerator program. Mayo having a great reputation, it makes sense to keep an eye on what kinds of startups they accepted.
The field these companies cover is broad, and we are excited to monitor the new arrivals to the Mayo acceleration program.
领英推荐
The UK biotech company, FabRx believes it could even appear as a regular technique in hospitals and pharmacies for creating personalised drugs in specific doses within 5-10 years.
In February 2022 the company announced they developed a technology allowing them to 3D print tablets in 7-17 seconds, a huge improvement from earlier. Read our newest article on the topic to find out more.
The Swiss medtech company Bloom Diagnostics has introduced a kidney test, "designed for the quantitative measurement of cystatin C in whole blood".
It is intended to be used by medical professionals, such as doctors and pharmacists, to rapidly measure and quantify kidney function in adult users.
This concept can help you in business, on the job, and in your personal life to gain a better understanding of yourself.
"Longtermism is the view that positively influencing the long-term future is a key moral priority of our time. It's about taking seriously the sheer scale of the future, and how high the stakes might be in shaping it."
MORE NEWS ABOUT THE FUTURE OF MEDICINE
AHA SAYS? – Four ways to improve digital health equity
PREDICTING STRUCTURES – Artificial intelligence tools predict DNA's regulatory role and 3D structure